AGRX News and Press, Agile Therapeutics Inc. From 04/11/23

2023-04-11 13:16:16 ET Gainers: Innovative Eyewear ( LUCY ) +157% . WW International ( WW ) +50% . Brenmiller Energy ( BNRG ) +45% . Brookdale Senior Living ( BKD ) +34% . ZeroFox Holdings ( ZFOX ) +31% . Kura Sushi USA ( K...

2023-04-11 10:02:34 ET Gainers: Innovative Eyewear ( LUCY ) +170% . Brookdale Senior Living ( BKD ) +20% . Apollomics ( APLM ) +16% . TG Therapeutics ( TGTX ) +16% . Butterfly Network ( BFLY ) +13% . Losers: GlucoTrac...

2023-04-10 16:57:48 ET Agile Therapeutics ( NASDAQ: AGRX ) said it had approved a 1-for-50 reverse stock split. The reverse stock split was approved by Agile’s stockholders on March 9, and will increase the per share trading price of the stock for the minimum bid price ...

PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women's healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Com...

2023-03-24 12:31:48 ET The following slide deck was published by Agile Therapeutics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Agile Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation

2023-03-24 12:31:03 ET Agile Therapeutics, Inc (AGRX) Q4 2022 Earnings Conference Call March 22, 2023 16:30 ET Company Participants Matt Riley - Head, Investor Relations Al Altomari - Chairman and Chief Executive Officer Amy Welsh - Chief Commercial Officer J...

2023-03-22 16:53:27 ET Agile Therapeutics press release ( NASDAQ: AGRX ): Q4 GAAP EPS of -$0.10 beats by $0.12 . Revenue of $4M (+164.9% Y/Y) beats by $0.87M . Shares +31.14% . For further details see: Agile Therapeutics GAAP EPS of -$0.10 beats b...

Fourth Quarter 2022 Net Revenue Increased 33% from Third Quarter 2022 While GAAP Quarter-Over-Quarter OPEX Decreased 55% and Non-GAAP OPEX Remained Unchanged Twirla Demand and Factory Sales Up 25% and 30% Respectively in Fourth Quarter 2022 vs Third Quarter 2022 Company Reaffirm...

PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 financial results after the market close on Wednesday, March 22, 2023. Following the release, the C...

Nasdaq has granted to the women's healthcare company Agile Therapeutics ( NASDAQ: AGRX ) a 180-day extension to regain compliance with the stock exchange's listing requirements. The company has until Aug. 14 to meet the requirement. The company was notified of its failure to maint...